Ganymede bills itself as the world’s first Platform-as-a-Service (PaaS) for biotech software engineering. It delivers a cloud-based platform, allowing scientists to automatically capture data, connect their lab instruments, and ultimately automate many aspects of their lab operations. The platform is capable of servicing early-stage biotechs all the way up to large pharmaceutical manufacturers
The originality of this offering gives the company an obvious edge, and further encouragement comes in the form of strong investment and industry interest. In 2026, it was announced that Ganymede would be acquired by Apprentice.io, which will result in the formation of the first AI-native platform spanning R&D through commercial manufacturing.
Kirsty
Company Specialist at Welcome to the Jungle